Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Identification of Clinical-Biological Features of Newly Diagnosed Early Relapse Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Lorenzo Cillo, Anna Benedetta Dalla Palma, Matteo Scita, Federica Librale, Matia Bernardi, Stefania Ricci, Gabriella Sammarelli, Giannalisa Todaro, Mario Pedrazzoni, Nicola Giuliani

Blood (2023) 142 (Supplement 1): 6637.

https://doi.org/10.1182/blood-2023-182835

Published: 2023

Journal Articles

Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass

Anna Benedetta Dalla Palma, MD, Laura Notarfranchi, MD, Jessica Crosara, MD, Mario Pedrazzoni, MD, Fabrizio Accardi, MD, Valentina Marchica, MS, Denise Toscani, PhD, Emanuela Vicario, PhD, Paola Storti, PhD, Nicola Giuliani

Blood (2019) 134 (Supplement_1): 1795.

https://doi.org/10.1182/blood-2019-128252

Published: 2019

Journal Articles

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Benedetta Dalla Palma, MD, Valentina Marchica, Fabrizio Accardi, MD, Daniela Guasco, Laura Notarfranchi, MD, Federica Costa, Martina Caviola, Federica De Luca, Luisa Craviotto, MD, Mario Pedrazzoni, MD PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 4452.

https://doi.org/10.1182/blood.V128.22.4452.4452

Published: 2016

Journal Articles

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Nicola Giuliani, MD, PhD, Benedetta Dalla Palma, MD, Daniela Guasco, Mario Pedrazzoni, MD, PhD, Marina Bolzoni, Gabriella Sammarelli, PhD, Paola Storti, PhD, Angelica Spolzino, MD, Luisa Craviotto, MD, Massimo De Filippo, MD, Livia Ruffini, MD, Franco Aversa, MD

Blood (2013) 122 (21): 3110.

https://doi.org/10.1182/blood.V122.21.3110.3110

Published: 2013

Journal Articles

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Denise Toscani, Benedetta Dalla Palma, MD, Carla Palumbo, Marzia Ferretti, Marina Bolzoni, Daniela Guasco, Cristina Mancini, MD, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Mario Pedrazzoni, MD, PhD, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 3978.

https://doi.org/10.1182/blood.V120.21.3978.3978

Published: 2012

Journal Articles

DKK-1 and sFRP-3 Expression by Myeloma Cell and Bone Marrow Plasma Levels in Multiple Myeloma and MGUS Patients: Potential Relationship with Bone Status.

Nicola Giuliani, Francesca Morandi, Sara Tagliaferri, Luca Agnelli, Katia Todoerti, Mario Pedrazzoni, Monica Crugnola, Giorgio Lambertenghi Deliliers, Vittorio Rizzoli, Antonino Neri

Blood (2006) 108 (11): 3437.

https://doi.org/10.1182/blood.V108.11.3437.3437

Published: 2006

Journal Articles

Shortage of circulating naive CD8 + T cells provides new insights on immunodeficiency in aging

Francesco F. Fagnoni, Rosanna Vescovini, Giovanni Passeri, Giovanni Bologna, Mario Pedrazzoni, Giampaolo Lavagetto, Amos Casti, Claudio Franceschi, Mario Passeri, Paolo Sansoni

Blood (2000) 95 (9): 2860–2868.

https://doi.org/10.1182/blood.V95.9.2860.009k35_2860_2868

Published: 2000

NARROW

Identification of Clinical-Biological Features of Newly Diagnosed Early Relapse Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

DKK-1 and sFRP-3 Expression by Myeloma Cell and Bone Marrow Plasma Levels in Multiple Myeloma and MGUS Patients: Potential Relationship with Bone Status.

Shortage of circulating naive CD8 + T cells provides new insights on immunodeficiency in aging

Email alerts

ASH Publications

American Society of Hematology

Identification of Clinical-Biological Features of Newly Diagnosed Early Relapse Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

DKK-1 and sFRP-3 Expression by Myeloma Cell and Bone Marrow Plasma Levels in Multiple Myeloma and MGUS Patients: Potential Relationship with Bone Status.

Shortage of circulating naive CD8 + T cells provides new insights on immunodeficiency in aging

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only